Skip to main content
Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 3/2022

13.12.2021 | Case Reports / Case Series

Spinal cord injury-related thermoregulatory impairment masks a fatal malignant hyperthermia crisis: a case report

verfasst von: Pamela V. Andrade, PhD, Lucas S. Souza, PhD, Joilson M. Santos, MSc, José F. F. Alves, MD, Claudia Lutke, MD, MSc, Jose L. G. Amaral, MD, PhD, Mariz Vainzof, PhD, Helga C. A. Silva, MD, PhD

Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Malignant hyperthermia (MH) is a hypermetabolic disorder that can occur in genetically susceptible individuals exposed to halogenated anesthetics and succinylcholine. Spinal cord injury (SCI) above the sixth thoracic vertebra is associated with dysfunction of the sympathetic/parasympathetic nervous pathways, including thermoregulatory dysfunction, presenting as hypothermia in cold environments because of vasodilation and heat loss. This effect could mitigate or obscure an MH episode. Here, we describe development of a fatal MH crisis in a patient with SCI.

Clinical features

A 27-yr-old male patient with an SCI after fracture of the sixth cervical vertebra was admitted for spinal arthrodesis. Anesthetic medications included remifentanil, propofol, succinylcholine, rocuronium, and isoflurane. After the start of the surgery, muscular contractures resembling myoclonus were noted, which resolved with pancuronium administration. Four hours after the start of anesthesia, the patient presented with hyperthermia, hypercarbia, hypotension, muscle rigidity, arrhythmia, and cardiogenic shock, with metabolic/respiratory acidosis. Malignant hyperthermia was suspected and the treatment was started, but he developed cardiopulmonary arrest and died an hour and a half after the first cardiac arrest. Both parents were investigated and were found to have normal creatine kinase levels and positive in vitro contracture tests. His mother carried a variant in the ryanodine receptor type 1 (RYR1) gene (c.14918C>T), which is associated with MH.

Conclusion

Spinal cord injury-induced thermoregulatory dysfunction may obscure the early diagnosis of MH and lead to fatal outcome.
Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
1
CARE. Case report guidelines. Available from URL: https://​www.​care-statement.​org (accessed October 2021).
 
2
ClinVar. Available from URL: https://​www.​ncbi.​nlm.​nih.​gov/​clinvar/​ (accessed October 2021).
 
3
European Malignant Hyperthermia Group. Scoring matrix for classification of genetic variants in malignant hyperthermia susceptibility. Available from URL: https://​www.​emhg.​org/​genetic-scoring-matrix (accessed October 2021).
 
Literatur
1.
2.
Zurück zum Zitat Butala B, Busada M, Cormican D. Malignant hyperthermia: review of diagnosis and treatment during cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2018; 32: 2771-9.CrossRef Butala B, Busada M, Cormican D. Malignant hyperthermia: review of diagnosis and treatment during cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2018; 32: 2771-9.CrossRef
3.
Zurück zum Zitat Silva HC, Ferreira G, Rodrigues G, et al. Profile of malignant hyperthermia susceptibility reports confirmed with muscular contracture test in Brazil (Portuguese). Braz J Anestesiol 2019; 69: 152-9.CrossRef Silva HC, Ferreira G, Rodrigues G, et al. Profile of malignant hyperthermia susceptibility reports confirmed with muscular contracture test in Brazil (Portuguese). Braz J Anestesiol 2019; 69: 152-9.CrossRef
4.
Zurück zum Zitat Larach MG. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesth Analg 1989; 69: 511-5. Larach MG. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesth Analg 1989; 69: 511-5.
5.
Zurück zum Zitat Anonymous. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group. Br J Anaesth 1984; 56: 1267-9. Anonymous. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group. Br J Anaesth 1984; 56: 1267-9.
6.
Zurück zum Zitat Larach MG, Localio AR, Allen GC, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994;8 6: 771-9.CrossRef Larach MG, Localio AR, Allen GC, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994;8 6: 771-9.CrossRef
7.
Zurück zum Zitat Hopkins PM, Rüffert H, Snoeck MM, et al. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility. Br J Anaesth 2015; 115: 531-9.CrossRef Hopkins PM, Rüffert H, Snoeck MM, et al. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility. Br J Anaesth 2015; 115: 531-9.CrossRef
8.
Zurück zum Zitat Hagen EM, Faerestrand S, Hoff JM, Rekand T, Gronning M. Cardiovascular and urological dysfunction in spinal cord injury. Acta Neurol Scand 2011; 124 (Suppl. 191): 71-8.CrossRef Hagen EM, Faerestrand S, Hoff JM, Rekand T, Gronning M. Cardiovascular and urological dysfunction in spinal cord injury. Acta Neurol Scand 2011; 124 (Suppl. 191): 71-8.CrossRef
9.
Zurück zum Zitat Ulger F, Dilek A, Karakaya D, Senel A, Sarihasan B. Fatal fever of unknown origin in acute cervical spinal cord injury: five cases. J Spinal Cord Med 2009; 32: 343-8.CrossRef Ulger F, Dilek A, Karakaya D, Senel A, Sarihasan B. Fatal fever of unknown origin in acute cervical spinal cord injury: five cases. J Spinal Cord Med 2009; 32: 343-8.CrossRef
10.
Zurück zum Zitat Metterlein T, Zink W, Kranke E, Haneya A, Graf B, Kranke P. Cardiopulmonary bypass in malignant hyperthermia susceptible patients: a systematic review of published cases. J Thorac Cardiovasc Surg 2011; 141: 1488-95.CrossRef Metterlein T, Zink W, Kranke E, Haneya A, Graf B, Kranke P. Cardiopulmonary bypass in malignant hyperthermia susceptible patients: a systematic review of published cases. J Thorac Cardiovasc Surg 2011; 141: 1488-95.CrossRef
11.
Zurück zum Zitat Glahn KP, Bendixen D, Girard T, et al. Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines. Br J Anaesth 2020; 125: 133-40.CrossRef Glahn KP, Bendixen D, Girard T, et al. Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines. Br J Anaesth 2020; 125: 133-40.CrossRef
12.
Zurück zum Zitat Martyn JA, Richtsfeld M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology 2006; 104: 158-69.CrossRef Martyn JA, Richtsfeld M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology 2006; 104: 158-69.CrossRef
13.
Zurück zum Zitat Miller DM, Daly C, Aboelsaod EM, et al. Genetic epidemiology of malignant hyperthermia in the UK. Br J Anaesth 2018; 121: 944-52.CrossRef Miller DM, Daly C, Aboelsaod EM, et al. Genetic epidemiology of malignant hyperthermia in the UK. Br J Anaesth 2018; 121: 944-52.CrossRef
14.
Zurück zum Zitat Galli L, Orrico A, Cozzolino S, Pietrini V, Tegazzin V, Sorrentino V. Mutations in the RYR1 gene in Italian patients at risk for malignant hyperthermia: evidence for a cluster of novel mutations in the C-terminal region. Cell Calcium 2002; 32: 143-51.CrossRef Galli L, Orrico A, Cozzolino S, Pietrini V, Tegazzin V, Sorrentino V. Mutations in the RYR1 gene in Italian patients at risk for malignant hyperthermia: evidence for a cluster of novel mutations in the C-terminal region. Cell Calcium 2002; 32: 143-51.CrossRef
15.
Zurück zum Zitat Monnier N, Krivosic-Horber R, Payen JF, et al. Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology 2002; 97: 1067-74.CrossRef Monnier N, Krivosic-Horber R, Payen JF, et al. Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology 2002; 97: 1067-74.CrossRef
16.
Zurück zum Zitat Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-24.CrossRef Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-24.CrossRef
17.
Zurück zum Zitat Chen W, Koop A, Liu Y, et al. Reduced threshold for store overload-induced Ca(2+) release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease. Biochem J 2017; 474: 2749-61.CrossRef Chen W, Koop A, Liu Y, et al. Reduced threshold for store overload-induced Ca(2+) release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease. Biochem J 2017; 474: 2749-61.CrossRef
Metadaten
Titel
Spinal cord injury-related thermoregulatory impairment masks a fatal malignant hyperthermia crisis: a case report
verfasst von
Pamela V. Andrade, PhD
Lucas S. Souza, PhD
Joilson M. Santos, MSc
José F. F. Alves, MD
Claudia Lutke, MD, MSc
Jose L. G. Amaral, MD, PhD
Mariz Vainzof, PhD
Helga C. A. Silva, MD, PhD
Publikationsdatum
13.12.2021
Verlag
Springer International Publishing
Erschienen in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Ausgabe 3/2022
Print ISSN: 0832-610X
Elektronische ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-021-02170-4

Weitere Artikel der Ausgabe 3/2022

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 3/2022 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.